President Donald Trump signed a new executive order Monday aimed at slashing the cost of prescription drugs in the United ...

As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...

President Trump signed an executive order Monday that will attempt to bring down the cost of some drugs in the United ... prices will affect innovation and development of new medicines.

HHM Health pharmacy director Dr. Riz Islam and Fox News host Will Cain explain why America has uniquely high drug prices on ...

AI business Recursion Pharmaceuticals has narrowed its drug development ... Recursion is pausing development of REC-4539, a clinical-stage oncology candidate. A preclinical programme in an ...

On Sunday, Trump took aim at the industry again, writing that the “Pharmaceutical/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs ...

Activist Commentary: Elliott is a very successful and astute activist investor. The firm's team includes analysts from ...